UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures

Immunologic research, 2017-02, Vol.65 (1), p.150-156

2017

Link zum Volltext

Verfügbarkeit prüfen

Proliferation index as a prognostic marker in breast cancer

Cancer, 1993-06, Vol.71 (12), p.3926-3931

1993

Link zum Volltext

Verfügbarkeit prüfen

Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group

British journal of cancer, 2009-05, Vol.100 (10), p.1566-1574

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1356-1363

International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators

1999

Link zum Volltext

Verfügbarkeit prüfen

Age as a prognostic factor in primary non Hodgkin lymphoma of the stomach

Haematologica (Roma), 1992-01, Vol.77 (1), p.87

1992

Link zum Volltext

Verfügbarkeit prüfen

Pancreatic cystadenocarcinoma and pregnancy: a case report

Tumori, 1990-06, Vol.76 (3), p.294

1990

Link zum Volltext

Verfügbarkeit prüfen

Clinical and prognostic usefulness of immunohistochemical determination of Ki67 in breast cancer

Breast (Edinburgh), 1993, Vol.2 (1), p.33-36

1993

Link zum Volltext

Verfügbarkeit prüfen

Histology as a prognostic factor in early gastric cancer

Tumori, 1992-06, Vol.78 (3), p.181

1992

Link zum Volltext

Verfügbarkeit prüfen

Possible correlation between some biologic effects and the clinical course in patients treated with continuous infusion of interleukin-2 plus alpha-2 interferon for metastatic renal cell carcinoma

Tumori, 1994-10, Vol.80 (5), p.348

1994

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemotherapy in bladder cancer: Is cistectomy mandatory in case of complete response?

European journal of cancer (1990), 1997-09, Vol.33, p.S36-S36

1997

Link zum Volltext

Verfügbarkeit prüfen

468 Metastatic renal cell carcinoma (MRCC): Responses to different immunotherapies

European journal of cancer (1990), 1995-11, Vol.31, p.S100-S101

1995

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous administration of interleukin 2 and interferon-alpha-2b in advanced renal cell carcinoma: a confirmatory study

British journal of cancer, 1995-12, Vol.72 (6), p.1531-1535

1995

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-2 (IL-2) and alpha-2 Interferon in metastatic renal cell carcinoma (MRCC): Analysis of 22 cases

European journal of cancer (1990), 1994, Vol.30, p.S11-S11

1994

Link zum Volltext

Verfügbarkeit prüfen

Treatment results in pT2, NO1 breast cancer. )A retrospective analysis of 85 cases

Annali italiani di chirurgia, 1993-05, Vol.64 (3), p.281

1993

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous administration of interleukin-2 and interferon-alpha 2b in advanced renal cell carcinoma: long-term results

Cancer detection and prevention, 1999, Vol.23 (2), p.172

1999

Link zum Volltext

Verfügbarkeit prüfen

Clinical and prognostic usefulness of Ki67 determination in breast carcinoma

Pathologica, 1992-11, Vol.84 (1094), p.15

1992

Link zum Volltext

Verfügbarkeit prüfen

Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn’s Disease Treated with Anti-Tumour Necrosis Factor Therapy

Journal of Crohn's and colitis, 2020-11, Vol.14 (11), p.1524-1534

2020

Link zum Volltext

Verfügbarkeit prüfen

Colonic overexpression of the T‐type calcium channel Cav3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients

Neurogastroenterology and motility, 2016-11, Vol.28 (11), p.1632-1640

2016

Link zum Volltext

Verfügbarkeit prüfen

Colonic overexpression of the T-type calcium channel Cav 3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients

Neurogastroenterology and motility, 2016-11, Vol.28 (11), p.1632-1640

2016

Link zum Volltext

Verfügbarkeit prüfen

Colonic overexpression of the T-type calcium channel Ca v 3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients

Neurogastroenterology and motility, 2016-11, Vol.28 (11), p.1632-1640

2016

Link zum Volltext

Verfügbarkeit prüfen

Colonic overexpression of the T-type calcium channel Ca sub(v)3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients

Neurogastroenterology and motility, 2016-11, Vol.28 (11), p.1632-1640

2016

Link zum Volltext

Verfügbarkeit prüfen

DOP013 Definition of therapeutic response criteria using MRI in Crohn's disease patients treated with anti-TNF therapy: a multicenter prospective study (the IRMA study)

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S33-S33

2017

Link zum Volltext

Verfügbarkeit prüfen

Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis

Clinica terapeutica, 1994-01, Vol.144 (1), p.23

1994

Link zum Volltext

Verfügbarkeit prüfen

Peptic ulcer and Helicobacter pylori. Comments on the authors' cases

Recenti progressi in medicina, 1993-01, Vol.84 (1), p.34

1993

Link zum Volltext

Verfügbarkeit prüfen

Constipation. A critical review

Minerva medica, 1991-09, Vol.82 (9), p.585

1991

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(27)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(18)
Female
(16)
Middle Aged
(13)
Male
(12)
Adult
(11)
Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Aged
(10)
Oncology
(8)
Prognosis
(5)
Aged, 80 And Over
(4)
Biological And Medical Sciences
(4)
Medical Sciences
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Interferon-Alpha - Administration & Dosage
(3)
Interleukin-2 - Administration & Dosage
(3)
Irritable Bowel Syndrome
(3)
Survival Analysis
(3)
Animals
(2)
Antineoplastic Agents
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures

Proliferation index as a prognostic marker in breast cancer

Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group

Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer

Age as a prognostic factor in primary non Hodgkin lymphoma of the stomach

Pancreatic cystadenocarcinoma and pregnancy: a case report

Clinical and prognostic usefulness of immunohistochemical determination of Ki67 in breast cancer

Histology as a prognostic factor in early gastric cancer

Possible correlation between some biologic effects and the clinical course in patients treated with continuous infusion of interleukin-2 plus alpha-2 interferon for metastatic renal cell carcinoma

Neoadjuvant chemotherapy in bladder cancer: Is cistectomy mandatory in case of complete response?

468 Metastatic renal cell carcinoma (MRCC): Responses to different immunotherapies

Subcutaneous administration of interleukin 2 and interferon-alpha-2b in advanced renal cell carcinoma: a confirmatory study

Interleukin-2 (IL-2) and alpha-2 Interferon in metastatic renal cell carcinoma (MRCC): Analysis of 22 cases

Treatment results in pT2, NO1 breast cancer. )A retrospective analysis of 85 cases

Subcutaneous administration of interleukin-2 and interferon-alpha 2b in advanced renal cell carcinoma: long-term results

Clinical and prognostic usefulness of Ki67 determination in breast carcinoma

Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn’s Disease Treated with Anti-Tumour Necrosis Factor Therapy

Colonic overexpression of the T‐type calcium channel Cav3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients

Colonic overexpression of the T-type calcium channel Cav 3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients

Colonic overexpression of the T-type calcium channel Ca v 3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients

Colonic overexpression of the T-type calcium channel Ca sub(v)3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients

DOP013 Definition of therapeutic response criteria using MRI in Crohn's disease patients treated with anti-TNF therapy: a multicenter prospective study (the IRMA study)

Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis

Peptic ulcer and Helicobacter pylori. Comments on the authors' cases

Constipation. A critical review

Suchergebnisse filtern